John Briggs
Family Medicine · Lillington, NCNPI 1598748220
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $929 and has fallen 85.8% since, to $132 in 2022.
Across 154 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$503
- AstraZeneca$380
- Sanofi-aventis U.S. LLC$183
- GSK$162
- Boehringer Ingelheim$160
- AbbVie$160
- plus $830 from 23 others
What the payments were for
- Food & beverage$2,36499%
- Gifts$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $503 |
| AstraZeneca | 26 | $380 |
| Sanofi-aventis U.S. LLC | 13 | $183 |
| GSK | 11 | $162 |
| Boehringer Ingelheim | 8 | $160 |
| AbbVie(2 entities) | 11 | $160 |
| Lilly USA, LLC | 7 | $110 |
| Pfizer | 7 | $105 |
| Johnson & Johnson | 5 | $76 |
| Abbott | 4 | $75 |
| Amgen | 5 | $65 |
| Viiv Healthcare Company | 3 | $58 |
| Amarin Pharma, Inc. | 3 | $50 |
| Bayer | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Merck | 2 | $28 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Gilead | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Cranial Technologies, Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Novartis | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
| Theratechnologies Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Circassia Inc. | 1 | $11 |
| Shire North American Group Inc | 1 | $11 |
| Seqirus USA Inc | 1 | $11 |
How this compares
$2,378 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Lillington
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.